The daily coronavirus cases in the UAE crossed the 1,000-mark for the first time in four months. Daily infections have seen an increase post Dec.6.
AstraZeneca also revealed in other findings that its preventative moniclonal antibody treatment, Evusheld, "retains neutralisation activity" against Omicron.
The health experts said that the booster dose is considered one of the most important factors for maintaining public health and the safety of community members, and it has a significant and effective role in enhancing acquired immunity to achieve maximum benefit, especially in the current circumstances in which the world is witnessing an increase in the number of registered cases.
The Ministry of Health conducts 340,100 tests as part of its plans to expand the scope of the tests, and reveals 148 new cases
The health experts said that based on studies and research issued by the World Health Organisation (WHO), it indicates that people who received a booster dose were less infected than those who did not receive the booster dose even if they were exposed to mild symptoms.
The Ministry stressed in a statement on Monday that its aim to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment.
"At a time where the Omicron variant is rapidly spreading, and where we need to step up vaccination and the administration of boosters, I am particularly pleased with today's authorisation of the Novavax vaccine," said EU chief Ursula von der Leyen.
The sultanate also cancelled a previous decision that suspended entry from South Africa, Namibia, Botswana, Zimbabwe, Lesotho, Eswatini and Mozambique.
The new vaccine will be produced and distributed by Hayat Biotech, a JV between G42 and Sinopharm CNBG, while the vaccine will be available to the public as a booster dose starting January 2022 as part of the measures taken to contain the virus spread.